Seven Grand Managers LLC Acquires 50,000 Shares of Heartflow, Inc. $HTFL

Seven Grand Managers LLC boosted its holdings in shares of Heartflow, Inc. (NASDAQ:HTFL) by 100.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,000 shares of the company’s stock after acquiring an additional 50,000 shares during the period. Seven Grand Managers LLC owned about 0.12% of Heartflow worth $2,915,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. Legal & General Group Plc bought a new stake in shares of Heartflow in the 3rd quarter valued at about $59,000. Strs Ohio bought a new stake in shares of Heartflow in the 4th quarter valued at about $99,000. Staley Capital Advisers Inc. bought a new stake in shares of Heartflow in the 4th quarter valued at about $204,000. Connable Office Inc. bought a new stake in shares of Heartflow in the 4th quarter valued at about $220,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Heartflow in the 3rd quarter valued at about $234,000.

Insider Buying and Selling at Heartflow

In related news, insider Campbell Rogers sold 9,219 shares of the firm’s stock in a transaction on Monday, May 18th. The shares were sold at an average price of $28.34, for a total transaction of $261,266.46. Following the completion of the transaction, the insider owned 78,731 shares of the company’s stock, valued at $2,231,236.54. This trade represents a 10.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 22,562 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $29.12, for a total transaction of $657,005.44. Following the completion of the sale, the chief executive officer directly owned 519,397 shares in the company, valued at approximately $15,124,840.64. The trade was a 4.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 2,215,093 shares of company stock worth $64,427,995. Company insiders own 7.70% of the company’s stock.

Heartflow Trading Up 3.1%

Shares of Heartflow stock opened at $29.28 on Thursday. Heartflow, Inc. has a 12-month low of $20.13 and a 12-month high of $41.22. The firm has a market capitalization of $2.53 billion and a price-to-earnings ratio of -9.41. The firm’s 50 day simple moving average is $28.23 and its two-hundred day simple moving average is $28.37.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The company had revenue of $52.59 million for the quarter. The company’s revenue for the quarter was up 41.3% on a year-over-year basis. On average, sell-side analysts predict that Heartflow, Inc. will post -0.78 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HTFL. Wells Fargo & Company raised their price target on shares of Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a report on Friday, May 15th. William Blair assumed coverage on shares of Heartflow in a report on Monday, May 4th. They issued an “outperform” rating on the stock. JPMorgan Chase & Co. lowered their target price on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a research note on Thursday, March 19th. Finally, Canaccord Genuity Group cut their price target on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating on the stock in a research note on Friday, May 15th. Six investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $37.00.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.